• Your shopping cart is empty!

Speaker Profile
EDWARD O'CONNOR

Edward O’Connor has over 25 years in GxP labs as director, associate director of labs. In that capacity he has directed method development and method, software, process, instrument and computer system validation and as QA Manager in Pharma, Biotech and CROs in same. Dr. O’Connor also managed the selection of several CRO to support analytical and bioanalytical work supporting GMP, GLP and GCP projects.


Product Compare (0)
$199.00
Sample Reanalysis

 Edward O'connor
 April 22 2025
 11 : 00 AM EST    
 60 Minutes
Sample Reanalysis

Sample re-analysis may be required for numerous reasons. Assay failure is the most common and the clearest. Individual re-analysis is usually justified by the lack of internal standards or the failure to meet chromatographic parameters such as retention time or peak shape. In ligand binding assays and chromatographic assays, the color or peak height may exceed expectations or fall below expectations. These&..

$199.00
Applying Six Sigma "Downtime" in the Bioanalytical Lab

 Edward O'connor
 May 20 2025
 11 : 00 AM EST    
 60 Minutes
Applying Six Sigma "Downtime" in the Bioanalytical Lab

Applies the consideration of the acronym "DOWNTIME" to improve function and efficiency in the LAB. - Defects- reduce or eliminate - Overproduction reduces waste of materials, time, and personnel - Waiting to eliminate waiting on resource access or permission - Non-utilized resources- instruments, personnel - Transportation-movement (temporal or spatial) of resources/or documents&nbs..

$199.00
Clinical Sample Analysis: Considerations for the Bioanalytical Lab

 Edward O'connor
 June 17 2025
 11 : 00 AM EST    
 60 Minutes
Clinical Sample Analysis: Considerations for the Bioanalytical Lab

Reviews the history of the GCPs from Tuskegee to Nuremberg, Helsinki to the current 21 CFR and other protections, demonstrating the evolution of the regulation's current status. Particular focus will be on constraints, including requirements for informed consent and the disposition of samples. Several illustrations of recent violations will be provided, along with the consequences. Areas CoveredEvolution of..

$199.00
Selecting a CRO to Support GxP Analytical and Bioanalytical

 Edward O'connor
 July 17 2025
 11 : 00 AM EST    
 60 Minutes
Selecting a CRO to Support GxP Analytical and Bioanalytical

This Webinar suggests objective components in the selection of CRO.Components include inspection and rebuttal of warning letters and 483 issued by the FDA or other regulatory entity, and answers/defense of the same by the CRO.  Areas Covered    Philosophy of the CRO to meet regulatory requirements, interpretation of suitability exercises. Philosophy of training skills and skill..

Showing 1 to 4 of 4 (1 Pages)
Showing 1 to 4 of 4 (1 Pages)